Drug General Information
Drug ID
D03CEF
Former ID
DAP001469
Drug Name
Desvenalfaxine succinate
Drug Type
Small molecular drug
Indication Fibromyalgia [ICD9: 729.1; ICD10:M79.7] Approved [536647]
Company
Wyeth
Structure
Download
2D MOL

3D MOL

Formula
C20H33NO7
Canonical SMILES
CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O.C(CC(=O)O)C(=O)O.O
InChI
1S/C16H25NO2.C4H6O4.H2O/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16;5-3(6)1-2-4(7)8;/h6-9,15,18-19H,3-5,10-12H2,1-2H3;1-2H2,(H,5,6)(H,7,8);1H2
InChIKey
PWPDEXVGKDEKTE-UHFFFAOYSA-N
CAS Number
CAS 386750-22-7
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Sodium-dependent noradrenaline transporter Target Info Inhibitor [536647]
PANTHER Pathway Adrenaline and noradrenaline biosynthesis
Reactome Na+/Cl- dependent neurotransmitter transporters
WikiPathways Monoamine Transport
NRF2 pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 536647Emerging therapies for fibromyalgia. Expert Opin Emerg Drugs. 2008 Mar;13(1):53-62.
Ref 536647Emerging therapies for fibromyalgia. Expert Opin Emerg Drugs. 2008 Mar;13(1):53-62.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.